1. Home
  2. INSP vs STOK Comparison

INSP vs STOK Comparison

Compare INSP & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$56.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$33.49

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
STOK
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
INSP
STOK
Price
$56.42
$33.49
Analyst Decision
Buy
Strong Buy
Analyst Count
16
10
Target Price
$94.00
$39.20
AVG Volume (30 Days)
894.4K
648.1K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
92.73
EPS
4.89
N/A
Revenue
$82,050,000.00
$184,420,000.00
Revenue This Year
$8.02
N/A
Revenue Next Year
$8.11
$77.49
P/E Ratio
$11.46
N/A
Revenue Growth
62.18
404.50
52 Week Low
$48.30
$8.30
52 Week High
$163.35
$40.22

Technical Indicators

Market Signals
Indicator
INSP
STOK
Relative Strength Index (RSI) 51.49 45.21
Support Level $53.11 $32.70
Resistance Level $60.15 $35.06
Average True Range (ATR) 3.19 1.60
MACD 0.52 -0.06
Stochastic Oscillator 69.66 31.16

Price Performance

Historical Comparison
INSP
STOK

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: